Novel Nasal Brushing Technique from the Lab of Dr. Mark Albers
An innovative nasal brushing technique spearheaded by Mark Albers, MD, PhD, is sparking excitement in ALS research. Learn more.
Request an appointment or second opinion with the Fertility Center or refer a patient.
Explore infertility research at the Massachusetts General Hospital Fertility Center and search open clinical trials and medical studies.
The Vincent Center for Reproductive Biology consists of basic and clinical scientists whose primary research emphasis includes infertility, aging and cancer as they pertain to the ovary and uterus. The center provides an optimal environment for individuals who are interested in integrating clinical and basic sciences and have a strong desire to pursue a career in academic research.
Search for clinical trials and research studies currently seeking participants.
The START Study tracks women’s mood symptoms throughout infertility treatment cycles. Study participants include women with a history of major depression or bipolar depression currently in remission who are planning or are under going infertility treatment. (Ongoing but not enrolling)
Advances in Motion highlights the latest breakthroughs, research and clinical trials from Mass General.
Our program trains OB/GYN subspecialists to manage complex infertility and reproductive endocrinology issues with an emphasis on research.
The Department of Obstetrics and Gynecology at Mass General has advanced the science and the quality of care for patients since 1891.
An innovative nasal brushing technique spearheaded by Mark Albers, MD, PhD, is sparking excitement in ALS research. Learn more.
The findings point to a new treatment strategy to improve immune-based treatments for basal cell carcinoma.
Cancer research and innovative treatments, like immunotherapy, are helping cancer patients with advanced disease live longer.
Physician-scientists at Massachusetts General Hospital are leading a clinical trial assessing the effectiveness of cell therapy to reinforce weakened tissue associated with fecal incontinence.
The authors developed a “cell line atlas” which serves as a resource to help better understand BTC biology and to guide the development of more effective, personalized treatment strategies.
The Sean M. Healey & AMG Center for ALS is thrilled to announce the 2025 MGH ALS Young Investigator Awards. These awards celebrate the work of researchers and innovators in the field of ALS research.
An innovative nasal brushing technique spearheaded by Mark Albers, MD, PhD, is sparking excitement in ALS research. Learn more.
The findings point to a new treatment strategy to improve immune-based treatments for basal cell carcinoma.
Cancer research and innovative treatments, like immunotherapy, are helping cancer patients with advanced disease live longer.
Physician-scientists at Massachusetts General Hospital are leading a clinical trial assessing the effectiveness of cell therapy to reinforce weakened tissue associated with fecal incontinence.
OB/GYN Advances is an update for health care professionals from specialists at Massachusetts General Hospital on research and clinical advances in obstetrics and gynecology.